Lianyungang, China

Wenjun Liu

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenjun Liu. Retrieved from https://idiyas.com/inventor/wenjun-liu-ynhygg2c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wenjun Liu: Innovator in Traditional Chinese Medicine

Introduction

Wenjun Liu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of traditional Chinese medicine. His innovative work focuses on developing compositions that can alleviate various health issues.

Latest Patents

Wenjun Liu holds a patent for a traditional Chinese medicine composition, which includes a preparation method and its uses. The composition contains specific percentages of various compounds, including 0.214% or above of gallic acid, 0.008% or above of 4-hydroxybenzoic acid, and 1.112% or above of paeoniflorin, among others. This formulation is designed to alleviate dysmenorrhea, showcasing Liu's commitment to improving women's health through traditional remedies. He has 1 patent to his name.

Career Highlights

Wenjun Liu is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work is characterized by a blend of traditional knowledge and modern scientific methods, which enhances the efficacy of traditional Chinese medicine.

Collaborations

Wenjun Liu collaborates with Ziyan Dong, contributing to the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Wenjun Liu's contributions to traditional Chinese medicine highlight the importance of innovation in healthcare. His patent reflects a dedication to improving health outcomes through traditional practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…